A detailed history of Catalytic Wealth Ria, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 11,260 shares of ABT stock, worth $1.29 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
11,260
Previous 9,812 14.76%
Holding current value
$1.29 Million
Previous $1.02 Billion 25.91%
% of portfolio
0.22%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$100.07 - $118.13 $144,901 - $171,052
1,448 Added 14.76%
11,260 $1.28 Billion
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $111,004 - $123,908
1,102 Added 12.65%
9,812 $1.02 Billion
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $195,383 - $215,792
1,784 Added 25.76%
8,710 $990 Million
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $624,655 - $764,630
6,926 New
6,926 $762 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Catalytic Wealth Ria, LLC Portfolio

Follow Catalytic Wealth Ria, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalytic Wealth Ria, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalytic Wealth Ria, LLC with notifications on news.